AndreaBozzo/ceres-open-data-index huggingface dataset:
California Drug and Alcohol Treatment Assessment (CALDATA-1991-1993)

<p>The California Drug and Alcohol Treatment Assessment<br />
(CALDATA) was designed to study the costs, benefits, and effectiveness<br />
of the state's alcohol and drug treatment infrastructure (recovery<br />
services) and specifically to assess (1) the effects of treatment on<br />
participant behavior, (2) the costs of treatment, and (3) the economic<br />
value of treatment to society. Data were collected on participants<br />
(clients) across four types of treatment programs, or modalities:<br />
residential, residential "social model," nonmethadone outpatient, and<br />
outpatient methadone (detoxification and maintenance). Data were<br />
collected in two phases. In Phase 1, treatment records were abstracted<br />
for clients who received treatment or were discharged between October<br />
1, 1991, and September 30, 1992. In Phase 2, these clients were<br />
located and recruited for a follow-up interview. The CALDATA design<br />
and procedures included elements from several national treatment<br />
outcome studies including the Drug Services Research Survey, Services Research Outcomes Study, National<br />
Treatment Improvement Evaluation Study, and Drug Abuse<br />
Treatment Outcome Study. The record abstract was designed<br />
to collect identifying and locating information for interview<br />
reference during the personal interviewing phase. The abstract also<br />
collected demographic, drug, or alcohol use, and treatment and service<br />
information. The follow-up questionnaire covered time periods before,<br />
during, and after treatment and focused on topics such as ethnic and<br />
educational background, drug and alcohol use, mental and physical<br />
health, HIV and AIDS status, drug testing, illegal activities and<br />
criminal status, living arrangements and family issues, employment and<br />
income, and treatment for drug, alcohol, and mental health<br />
problems. Drugs included alcohol, barbiturates, benzodiazepines,<br />
cocaine powder, crack, downers, hallucinogens, heroin, illegal<br />
methadone, inhalants, LSD, marijuana/hashish/THC, methamphetamines and<br />
other stimulants, narcotics, over-the-counter drugs, PCP, ritalin or<br />
preludin, and sedatives/hypnotics. CALDATA was originally known as the<br />
California Outcomes Study (COS).This study has 1 Data Set.</p>
Compound 528660: Mevalonic lactone, trimethylsilyl

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-4-trimethylsilyloxyoxan-2-one. Molecular Formula: C9H18O3Si. Molecular Weight: 202.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis

Background
          NF1 refers to type 1 neurofibromatosis syndrome, which has been linked with mutations of the large NF1 gene. NF1 tumor suppressor protein, neurofibromin, has been shown to regulate ras: the NF1 protein contains a GTPase activating protein (GAP) related domain which functions as p21rasGAP. Our studies have previously demonstrated that the NF1 protein forms a high affinity association with cytokeratin 14 during the formation of desmosomes and hemidesmosomes in cultured keratinocytes.
        
        
          Methods
          The expression of NF1 protein was studied in developing human epidermis using western transfer analysis, indirect immunofluorescence, confocal laser scanning microscopy, immunoelectron microscopy, and in situ hybridization.
        
        
          Results
          The expression of NF1 protein was noted to be highly elevated in the periderm at 8 weeks estimated gestational age (EGA) and in the basal cells at 8–14 weeks EGA. During this period, NF1 protein was associated with cytokeratin filaments terminating to desmosomes and hemidesmosomes. NF1 protein did not display colocalization with α-tubulin or actin of the cytoskeleton, or with adherens junction proteins.
        
        
          Conclusions
          These results depict an early fetal period when the NF1 tumor suppressor is abundantly expressed in epidermis and associated with cytokeratin filaments. This period is characterized by the initiation of differentiation of the basal cells, maturation of the basement membrane zone as well as accentuated formation of selected cellular junctions. NF1 tumor suppressor may function in the regulation of epidermal histogenesis via controlling the organization of the keratin cytoskeleton during the assembly of desmosomes and hemidesmosomes.
Compound 529069: Pyrrolidino[1,2-e]-4H-1,3,5-dithiazine, 4-methyl-2-(2-methylpropyl)

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-2-(2-methylpropyl)-6,7,8,8a-tetrahydro-4H-pyrrolo[2,1-d][1,3,5]dithiazine. Molecular Formula: C11H21NS2. Molecular Weight: 231.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526318: 2,3,6,7-Tetrabromo-1,9-dichloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 2,3,6,7-tetrabromo-1,9-dichlorodibenzo-p-dioxin. Molecular Formula: C12H2Br4Cl2O2. Molecular Weight: 568.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530589: 2-Chlorobenzoic acid, pentadecyl ester

Chemical compound data from PubChem database. IUPAC Name: pentadecyl 2-chlorobenzoate. Molecular Formula: C22H35ClO2. Molecular Weight: 367.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Conducting systematic reviews of diagnostic studies: didactic guidelines

Background
          Although guidelines for critical appraisal of diagnostic research and meta-analyses have already been published, these may be difficult to understand for clinical researchers or do not provide enough detailed information.
        
        
          Methods
          Development of guidelines based on a systematic review of the evidence in reports of systematic searches of the literature for diagnostic research, of methodological criteria to evaluate diagnostic research, of methods for statistical pooling of data on diagnostic accuracy, and of methods for exploring heterogeneity.
        
        
          Results
          Guidelines for conducting diagnostic systematic reviews are presented in a stepwise fashion and are followed by comments providing further information. Examples are given using the results of two systematic reviews on the accuracy of the urine dipstick in the diagnosis of urinary tract infections, and on the accuracy of the straight-leg-raising test in the diagnosis of intervertebral disc hernia.
Compound 525337: 3,3-Dimethyl-4-thianonane

Chemical compound data from PubChem database. IUPAC Name: 1-(2-methylbutan-2-ylsulfanyl)pentane. Molecular Formula: C10H22S. Molecular Weight: 174.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399839-T1: [Translated] LIQUID CLEANING AGENT BASED ON ANIONIC SURFACTANTS AND THEIR USE FOR WASHING HAIR

Liquid cleaning composition (I), comprises: an anionic surface-active; and an electrolyte a cross linked copolymer (II) of methacrylic acid and alkyl acrylate (with 1-4 carbon) (lower than 0.5 wt.% of active material compared to the total weight of (I)), in an aqueous medium. Liquid cleaning composition (I), comprises: an anionic surface-active; an electrolyte a cross linked copolymer (II) of methacrylic acid and 1-4C alkyl acrylate (lower than 0.5 wt.% of active material compared to the total weight of (I)), in an aqueous medium; provided composition is different from the formulation comprising Carbopol aqua SF-1(30%) (RTM; acrylate compolymer) (0.9 wt.%), Atlas G-4280(72%) (RTM; polyethylene glycol-80 sorbitan laurate) (4.58 wt.%), Tegobetaine L7V(30%) (RTM; cocoamidopropyl betaine) (11.33 wt.%), Glycerin 917(99%) (99%) (RTM; glycerin) (1.9 wt.%), Polymer JR-400(RTM; polyquaternium-10) (0.14 wt.%), Dowicil 200(RTM; quaternium-15) (0.05 wt.%), Versene 100 XL(RTM; tetrasodium EDTA) (0.263 wt.%) and water (to make 100 %). An independent claim is also included for cosmetic process of cleaning of stain residues on human keratinous material, comprises applying (I) on the keratinous material, in the presence of water, and allowing to form a foam and eliminating the formed foam and the stain residues by rinsing with water.
NSDUH 2019 Questionnaire Dwelling Unit-Level And Person Pair-Level Sampling Weight Calibration

NSDUH allows for estimating characteristics at the person level, pair level, and household or QDU level. This report describes the weight calibration methods used for the pair- and QDU-level respondents. As described in the person-level report, NSDUH is an annual survey of about 67,500 people selected from the civilian, noninstitutionalized population aged 12 or older from all 50 states and the District of Columbia. A coordinated sample design was developed for the 2014 through 2019 NSDUHs. The coordinated design facilitated 50 percent overlap in third-stage units (area segments) within each successive 2-year period from 2014 through 2019.
Compound 527396: Hexadeca-1,3-dien-5-yne

Chemical compound data from PubChem database. IUPAC Name: hexadeca-1,3-dien-5-yne. Molecular Formula: C16H26. Molecular Weight: 218.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526612: Ketobisnortilidine

Chemical compound data from PubChem database. IUPAC Name: ethyl 2-amino-5-oxo-1-phenylcyclohex-3-ene-1-carboxylate. Molecular Formula: C15H17NO3. Molecular Weight: 259.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399865-T1: [Translated] RECOMBINANT D-AMINO ACID OXIDASE

The present invention discloses two novel D-amino acid oxidases, whose activities of converting cephalosporin C to glutaryl-7-aminocephalosporanic acid are at least 25% higher than that of wild-type  Trigonopsis variabilis  D-amino acid oxidase and the encoding DNA sequences thereof.
Compound 527040: N-cyclobutyl-N-methyl-benzamide

Chemical compound data from PubChem database. IUPAC Name: N-cyclobutyl-N-methylbenzamide. Molecular Formula: C12H15NO. Molecular Weight: 189.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Kansas Intensive Permanency Project (KIPP) Permanency Innovations Initiative (PII) Grantee Profile

The University of Kansas, in partnership with the Kansas Department for Children and Families, and two private providers that comprise Kansas' statewide foster care network, is working to accelerate stable permanency for families of children with serious emotional disturbance (SED) by delivering intensive home-based parent training and support services shortly after children have been removed from their homes.

Metadata-only record linking to the original dataset. Open original dataset below.
NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b

NNDSS - TABLE 1M.  Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Data from California published in week 29 for years 2019 and 2020 were incomplete when originally published on July 24, 2020. On August 4, 2020, incomplete case counts were replaced with a "U" indicating case counts are not available for specified time period. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
2014 CMHS Uniform Reporting System (URS) Table for Indiana

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Indiana. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Cardiac Surgery and Percutaneous Coronary Interventions by Hospital:  Beginning 2008

This dataset contains the number of cases, number of in hospital/30 day deaths, observed, expected and risk- adjusted mortality rates for cardiac surgery and percutaneous coronary interventions (PCI) by hospital.  Regions represent where the hospitals are located. For additional information, visit: http://www.health.ny.gov/health_care/consumer_information/cardiac_surgery/
Compound 527498: 4a,8a-dimethyl-7-propan-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one

Chemical compound data from PubChem database. IUPAC Name: 4a,8a-dimethyl-7-propan-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Molecular Formula: C15H26O. Molecular Weight: 222.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
PKQuest: volatile solutes – application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics

Background
          The application of physiologically based pharmacokinetic models (PBPK) to human studies has been limited by the lack of the detailed organ information that is required for this analysis. PKQuest is a new generic PBPK that is designed to avoid this problem by using a set of "standard human" default parameters that are applicable to most solutes.
        
        
          Results
          PKQuest is used to model the human pharmacokinetics of the volatile solutes. A "standard human" value for the lipid content of the blood and each organ (klip) was chosen. This set of klip and the oil/water partition coefficient then specifies the organ/blood partition for each organ. Using this approach, the pharmacokinetics of inert volatile solute is completely specified by just 2 parameters: the water/air and oil/water partition coefficients. The model predictions of PKQuest were in good agreement with the experimental data for the inert solutes enflurane and nitrous oxide and the metabolized solutes halothane and toluene.
        
        
          Methods
          The experimental data that was modeled was taken from previous publications.
        
        
          Conclusions
          This approach greatly increases the predictive power of the PBPK. For inert volatile solutes the pharmacokinetics are determined just from the water/air and oil/water partition coefficient. Methoxyflurane cannot be modeled by this PBPK because the arterial and end tidal partial pressures are not equal (as assumed in the PBPK). This inequality results from the "washin-washout" artifact in the large airways that is established for solutes with large water/air partition coefficients.
          PKQuest and the worked examples are available on the web .
Patent AT-E400398-T1: [Translated] MULTI-AXIS MACHINE TOOL WITH FLEXIBLE RAIL AND METHOD

A flexible rail machine tool couples temporarily to a structure by vacuum cups and positions a tool head at any desired point over an area. The toolhead can perform operations such as drilling, bolt insertion, and acquisition of dimension data. The flexible rail can conform to surface curvature in one or more axes. Tool head perpendicularity to the structure can be sensed and adjusted as needed. The as-attached position of the rail may be compensated for through coordinate transformation, allowing holes, for example, to be placed with substantial precision.
2012 Uniform Reporting System (URS) Tables for Wisconsin

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 530623: 5-Chlorovaleric acid, 2,7-dimethylocty-7-en-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2,7-dimethyloct-7-en-5-yn-4-yl 5-chloropentanoate. Molecular Formula: C15H23ClO2. Molecular Weight: 270.79. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Project Tycho ® Level 2 Data

<p>US weekly Nationally Notifiable Disease Surveillance Data from 1888 to 2013. These data include  tables of disease counts reported by US states and cities to the Federal Health Authorities every week since 1888. These tables have been published in various journals over time and are available in various online repositories but are now also available in digital, computer-readable format.</p>
 <ul><li>API Help: http://www.tycho.pitt.edu/api_help.php</li><li>API Key: https://www.tycho.pitt.edu/apikey.php</li></ul>
Leucovorin calcium

Leucovorin Calcium is an injectable prescription drug, a folate analog, used to reduce toxicity from certain chemotherapy medications. It comes as a lyophilized powder for solution, administered intramuscularly or intravenously, with each vial containing 100 mg of leucovorin calcium. Manufactured by BluePoint Laboratories under ANDA089717. This information was generated using AI and is provided for informational and research purposes only.
Compound 528361: 1,2,3,5-Trithiazine, perhydro, 4,6-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 4,6-dimethyl-1,2,3,5-trithiazinane. Molecular Formula: C4H9NS3. Molecular Weight: 167.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Responding to Human Trafficking among Children and Youth in Foster Care and Missing from Foster Care

This joint Information Memorandum (IM) from the Administration on Children, Youth, and Families (ACYF); Children’s Bureau (CB); Family and Youth Services Bureau (FYSB); and the Office on Trafficking in Persons (OTIP) within the Administration for Children and Families (ACF) at the U.S. Department of Health and Human Services (HHS) provides an overview of federal statutes related to human trafficking among children and youth in the child welfare system and highlights resources to meet those requirements.

ACF-IM-22-01 (PDF)

Metadata-only record linking to the original dataset. Open original dataset below.
Weight loss maintenance in women two to eleven years after participating in a commercial program: a survey

Background
          After 5 years, most reports show that less than 10% of people maintain a 5% loss from initial body weight. Weight maintenance after 10 years is rarely assessed, especially in commercial programs. The current article reports weight maintenance in individuals who had participated 2 to 11 years earlier in a popular commercial weight loss program based on Canada's Food Guide called Mincavi.
        
        
          Methods
          Randomly picked subjects answered a telephone questionnaire. Participants, 291 adult women from various regions of the province of Quebec, had followed the program 2 to 11 years earlier for at least a month. Body weight at the beginning and at the end of treatment was recorded as well as actual weight, age and height. Existing records allowed partial verification of the sample.
        
        
          Results
          Based on corrected weights, percentage of women who maintained at least 5% of their initial weight loss are as following; 2 years = 43.6% (n = 55), 3 years = 33.3% (n = 42), 4 years = 23.8% (n = 42), 5–6 years = 38.2% (n = 55), 7–8 years = 29.4% (n = 51), and 9–11 years; 19.6% (n = 46). Five to eleven years after they had participated in the program 29.1% of all women maintained a weight loss of at least 5%, while 14.3% maintained a loss of at least 10%.
        
        
          Conclusions
          Even though success rate is not as high as could be wished for, results show that participation in the Mincavi program can lead to effective weight maintenance long after individuals have left it. These findings suggest more thorough studies should be conducted on this weight loss program.